Gerald Downey
Impact in
Papers in
- Oncology 8
- CAR-T cell therapy research 5
- Colorectal Cancer Treatments and Studies 2
-
- HIV/AIDS Research and Interventions 4
- HIV/AIDS drug development and treatment 4
- Co-authors
- Kevin J. Harrington (3 shared papers)Robert H.I. Andtbacka (2 shared papers)Howard L. Kaufman (2 shared papers)Frances A. Collichio (2 shared papers)Katarina Öhrling (3 shared papers)Mark R. Middleton (1 shared paper)Piero Picci (1 shared paper)Emanuela Palmerini (1 shared paper)
- Journals
- Pharmacoepidemiology and Drug Safety (3 papers)AIDS (2 papers)Tropical Medicine & International Health (2 papers)Research Synthesis Methods (1 paper)Technology in Cancer Research & Treatment (1 paper)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
Gerald Downey
19 papers receiving 848 citations
Peers
Comparison fields: 5 of 96
- Oncology 405
- Virology 55
- Immunology 205
- Genetics 221
- Oral Surgery 55
Countries citing papers authored by Gerald Downey
This map shows the geographic impact of Gerald Downey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald Downey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald Downey more than expected).
Fields of papers citing papers by Gerald Downey
This network shows the impact of papers produced by Gerald Downey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald Downey. The network helps show where Gerald Downey may publish in the future.
Co-authors
The 25 scholars most cited alongside Gerald Downey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 301 | |
| 2 | 2019 | 99 | |
| 3 | 2004 | 78 | |
| 4 | 2016 | 73 | |
| 5 | 2016 | 56 | |
| 6 | 2005 | 48 | |
| 7 | 2004 | 42 | |
| 8 | 2017 | 32 | |
| 9 | 2017 | 20 | |
| 10 | 2006 | 18 | |
| 11 | 2018 | 18 | |
| 12 | 2015 | 18 | |
| 13 | 2016 | 13 | |
| 14 | IMI-PROTECT benefit-risk grouprecommendations report:recommendations for the methodology andvisualisation techniques to be used in theassessment of benefit and risk of medicines | 2014 | 13 |
| 15 | 2018 | 10 | |
| 16 | 2008 | 8 | |
| 17 | 2015 | 7 | |
| 18 | 2017 | 6 | |
| 19 | 2003 | 4 |
About Gerald Downey
Gerald Downey is a scholar working on Oncology, Infectious Diseases, Immunology, Virology and Pulmonary and Respiratory Medicine, having authored 19 papers that have together received 864 indexed citations. Recurring topics across this work include CAR-T cell therapy research (5 papers), HIV/AIDS Research and Interventions (4 papers), Immunotherapy and Immune Responses (4 papers), HIV/AIDS drug development and treatment (4 papers), HIV Research and Treatment (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers), Virus-based gene therapy research (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Oncology (405 citations), Virology (55 citations), Immunology (205 citations), Genetics (221 citations) and Oral Surgery (55 citations). Gerald Downey has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Kevin J. Harrington, Robert H.I. Andtbacka, Howard L. Kaufman, Frances A. Collichio, Katarina Öhrling, Mark R. Middleton, Piero Picci, Emanuela Palmerini, Peter Reichardt and Mark Rowland. Their work appears in journals such as Pharmacoepidemiology and Drug Safety, AIDS, Tropical Medicine & International Health, Research Synthesis Methods and Technology in Cancer Research & Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.